Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.diabres.2014.01.011PMID 24513119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• US Renal Data System 2012 Annual Data Report.

  2013cited by this paper
• Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.

  2013cited by this paper
• Probucol suppresses initiation of chronic hemodialysis therapy and renal dysfunction-related death in diabetic nephropathy patients: Sakura study.

  2013cited by this paper
• Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.

  2013cited by this paper
• Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats

  2012cited by this paper
• Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes.

  2012cited by this paper
• Multiple Intravenous Transplantations of Mesenchymal Stem Cells Effectively Restore Long-Term Blood Glucose Homeostasis by Hepatic Engraftment and β-Cell Differentiation in Streptozocin-Induced Diabetic Mice

  2012cited by this paper
• Angiotensin-Converting Enzyme (ACE) 2 Overexpression Ameliorates Glomerular Injury in a Rat Model of Diabetic Nephropathy: A Comparison with ACE Inhibition

  2011cited by this paper
• Paracrine Interaction between Bone Marrow-derived Stem Cells and Renal Epithelial Cells

  2011cited by this paper
• Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.

  2011cited by this paper
• Oxidative stress and diabetic complications.

  2010cited by this paper
• Oxidative stress in diabetic nephropathy.

  2010cited by this paper
• Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.

  2010cited by this paper
• Mesenchymal Stem Cells Attenuate Renal Fibrosis Through Immune Modulation and Remodeling Properties in a Rat Remnant Kidney Model

  2009cited by this paper
• The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis.

  2009cited by this paper
• Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.

  2009cited by this paper
• Allogeneic Injection of Fetal Membrane‐Derived Mesenchymal Stem Cells Induces Therapeutic Angiogenesis in a Rat Model of Hind Limb Ischemia

  2008cited by this paper
• Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in Mice

  2008cited by this paper
• Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.

  2008cited by this paper
• Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes

  2008cited by this paper
• Rodent models of streptozotocin‐induced diabetic nephropathy (Methods in Renal Research)

  2007cited by this paper
• Adult bone marrow–derived stem cells for organ regeneration and repair

  2007cited by this paper
• Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.

  2006cited by this paper
• Impact of Mitochondrial ROS Production in the Pathogenesis of Diabetes Mellitus and Its Complications

  2006cited by this paper
• Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice

  2006cited by this paper
• Renal expression and localization of the facilitative glucose transporters GLUT1 and GLUT12 in animal models of hypertension and diabetic nephropathy.

  2006cited by this paper
• The human glomerular podocyte is a novel target for insulin action.

  2005cited by this paper
• Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney

  2005cited by this paper
• Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.

  2004cited by this paper
• Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure.

  2004cited by this paper
• Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000.

  2004cited by this paper
• Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF.

  2004cited by this paper
• Bone marrow–derived stem cells initiate pancreatic regeneration

  2003cited by this paper
• GLUT-1 Overexpression: Link Between Hemodynamic and Metabolic Factors in Glomerular Injury?

  2003cited by this paper
• Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats.

  2003cited by this paper
• Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.

  2003cited by this paper
• In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion.

  2003cited by this paper
• Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells.

  2002cited by this paper
• Transforming growth factor-β as a target for treatment in diabetic nephropathy

  2001cited by this paper
• Transforming growth factor-beta as a target for treatment in diabetic nephropathy.

  2001cited by this paper
• J Am Soc Nephrol 13: 894–902, 2002 Role of High Glucose–Induced Nuclear Factor–�B Activation in Monocyte Chemoattractant Protein-1 Expression by

  2001cited by this paper
• Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells.

  2001cited by this paper
• Transforming growth factor beta contributes to progressive diabetic nephropathy.

  2000cited by this paper
• Transforming growth factor β contributes to progressive diabetic nephropathy

  2000cited by this paper
• Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose.

  2000cited by this paper
• TGF-beta 1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells.

  1999cited by this paper
• GLUT-1 and TGF-beta: the link between hyperglycaemia and diabetic nephropathy.

  1999cited by this paper
• Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

  1999cited by this paper
• Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis.

  1998cited by this paper
• Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta.

  1994cited by this paper
• High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.

  1990cited by this paper
• High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells.

  1990cited by this paper
• Prevention of atherosclerotic progression in Watanabe rabbits by probucol.

  1988cited by this paper
• Probucol inhibits oxidative modification of low density lipoprotein.

  1986cited by this paper

• Combination therapy with bone marrow-derived mesenchymal stem cell transplantation and propolis improves streptozotocin-induced kidney injury in diabetic rats

  2026cites this paper
• The Role of Cell-Cell Communication in Renal Damage and the Therapeutic Targeting of Diabetic Kidney Disease

  2025cites this paper
• Mechanisms and clinical advances in the in vivo regeneration of renal tissue: a narrative review

  2025cites this paper
• The interaction between mesenchymal stem cells and macrophages in the inflammatory microenvironment

  2025cites this paper
• Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway

  2024cites this paper
• Role of Olive Leaf Extract, Mesenchymal Stem Cells or Low Radiation Dose in Alleviating Hepatic Injury in Rats

  2024cites this paper
• Protective effect of mesenchymal stromal cells in diabetic nephropathy: the In vitro and In vivo role of the M-Sec-tunneling nanotubes

  2024cites this paper
• Research advance in mesenchymal stem cell-based therapy for diabetic nephropathy

  2024cites this paper
• The pivotal role of glucose transporter 1 in diabetic kidney disease

  2024cites this paper
• Adipose-Derived Mesenchymal Stem Cells and Their Derived Epidermal Progenitor Cells Conditioned Media Ameliorate Skin Aging in Rats

  2024cites this paper
• The therapeutic effect of mesenchymal stem cells in diabetic kidney disease

  2024cites this paper
• Molecular Therapeutics for Diabetic Kidney Disease: An Update

  2024cites this paper
• Bone marrow mesenchymal stem cell-derived exosomal miR-30e-5p ameliorates high-glucose induced renal proximal tubular cell pyroptosis by inhibiting ELAVL1

  2023cites this paper
• BMSC reduces ROS and inflammation levels by inhibiting TLR4/MYD88/NF-κB signaling axis to alleviate dry eye

  2023cites this paper
• Anti-oxidative activities and anti-ferroptosis of conditioned medium from umbilical cord mesenchymal stem cells.

  2023cites this paper
• Secretome Derived from Mesenchymal Stem/Stromal Cells: A Promising Strategy for Diabetes and its Complications.

  2023cites this paper
• BM-MSCs alleviate diabetic nephropathy in male rats by regulating ER stress, oxidative stress, inflammation, and apoptotic pathways

  2023cites this paper
• Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management

  2022cites this paper
• Therapeutic role of mesenchymal stem cells (MSCs) in diabetic kidney disease (DKD).

  2022cites this paper
• An overview of the efficacy and signaling pathways activated by stem cell-derived extracellular vesicles in diabetic kidney disease

  2022cites this paper
• Ameliorative effect of bone marrow-derived mesenchymal stem cells on burn-induced hepatic and metabolic derangements in rats.

  2022cites this paper
• hucMSC-sEVs-Derived 14-3-3ζ Serves as a Bridge between YAP and Autophagy in Diabetic Kidney Disease

  2022cites this paper
• Human umbilical cord mesenchymal stem cells reduce oxidative damage and apoptosis in diabetic nephropathy by activating Nrf2

  2021cites this paper
• Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy

  2021cites this paper
• The Utility of Exosomes in Diagnosis and Therapy of Diabetes Mellitus and Associated Complications

  2021cites this paper
• Therapeutic Potential of Mesenchymal Stem Cells in a Pre-Clinical Model of Diabetic Kidney Disease and Obesity

  2021cites this paper
• Mesenchymal Stem Cells: An Overview of Their Potential in Cell-Based Therapy for Diabetic Nephropathy

  2021cites this paper
• Stem cell-based treatment of kidney diseases

  2020cites this paper
• Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats.

  2020cites this paper
• Regenerative Effect of EVs from MSCs against Renal Injury

  2020cites this paper
• Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis

  2020cites this paper
• Mesenchymal Stem Cells Transplantation in Diabetic Kidney Diseases: A Systematic Review and Meta-analysis

  2020cites this paper
• Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells

  2020cites this paper
• Transplant and Kidney Repair

  2020cites this paper
• The emerging antioxidant paradigm of mesenchymal stem cell therapy

  2020cites this paper
• Concise review: current trends on applications of stem cells in diabetic nephropathy

  2020cites this paper
• Adjunctive mesenchymal stem/stromal cells augment microvascular function in poststenotic kidneys treated with low‐energy shockwave therapy

  2020cites this paper
• Stem Cells in Urology

  2020cites this paper
• Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Renal Diseases

  2020cites this paper
• Mesenchymal Stem Cells Modified with Angiotensin-Converting Enzyme 2 are Superior for Amelioration of Glomerular Fibrosis in Diabetic Nephropathy.

  2020cites this paper
• Mesenchymal stem cells transplantation reduces diabetic nephropathy

  2019cites this paper
• Application of Ultrasound-Targeted Microbubble Destruction–Mediated Exogenous Gene Transfer in Treating Various Renal Diseases

  2019cites this paper
• Mesenchymal Stem Cells from Chronic Pancreatitis Patients Show Comparable Potency Compared to Cells from Healthy Donors

  2019cites this paper
• Are cell‐based therapies for kidney disease safe? A systematic review of preclinical evidence

  2019cites this paper
• Combination of Nonwoven Filters and Mesenchymal Stem Cells Reduced Glomerulosclerotic Lesions in Rat Chronic Kidney Disease Models

  2019cites this paper
• Role of bone marrow-derived stem cells versus insulin on filiform and fungiform papillae of diabetic albino rats (light, fluorescent and scanning electron microscopic study).

  2019cites this paper
• Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment

  2018cites this paper
• Mechanistic insights into the augmented effect of bone marrow mesenchymal stem cells and thiazolidinediones in streptozotocin-nicotinamide induced diabetic rats

  2018cites this paper
• Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy.

  2018cites this paper
• Renal Protective Effects of L-Carnitine on Lead-Induced Nephropathy in Wistar Rats

  2018cites this paper
• Improvement of the folliculogenesis by transplantation of bone marrow mesenchymal stromal cells in mice with induced polycystic ovary syndrome.

  2018cites this paper
• Paracrine effect of mesenchymal stem cell as a novel therapeutic strategy for diabetic nephropathy

  2018cites this paper
• Chapter 2 Human Amniotic Fluid-Derived and Amniotic Membrane-Derived Stem Cells

  2018cites this paper
• Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models

  2018cites this paper
• TFOS DEWS II pathophysiology report.

  2017cites this paper
• Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1/FOXO3a pathway.

  2017cites this paper
• Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy

  2017cites this paper
• Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy

  2017cites this paper
• Stem Cell and Regenerative Medicine

  2017cites this paper
• Amnion membrane · Mesenchymal stem cell · Amniotic fluid · Stem cell 2 . 1 Amniotic Membrane and Amniotic Fluid

  2017cites this paper
• Adipose‐derived stem cells ameliorate renal interstitial fibrosis through inhibition of EMT and inflammatory response via TGF‐&bgr;1 signaling pathway

  2017cites this paper
• Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.

  2017cites this paper
• Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy

  2017cites this paper
• Mesenchymal Stem Cell-Based Therapies against Podocyte Damage in Diabetic Nephropathy

  2017cites this paper
• The application of mesenchymal progenitor stem cells for the reduction of oxidative stress in animals

  2017cites this paper
• Ameliorative Effect of Mesenchymal Stromal Cells on Diabetic Nephropathy in Male Rats

  2017cites this paper
• Endothelial progenitor cells transplantation attenuated blood-brain barrier damage after ischemia in diabetic mice via HIF-1α

  2017cites this paper
• Clinical Transplantation of Mesenchymal Stromal Cell Therapies in Nephrology

  2017cites this paper
• The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease

  2016cites this paper
• Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy

  2016cites this paper
• Total saponin of Dioscoreae hypoglaucae rhizoma ameliorates streptozotocin-induced diabetic nephropathy

  2016cites this paper
• Cell-based Therapy for Treatment of Diabetes Mellitus: Can the Agonists of Growth Hormone-releasing Hormone Make a Contribution?

  2016cites this paper
• Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications

  2016cites this paper
• Bone Marrow-Derived Mesenchymal Stem cells Infusion Ameliorates Hyperglycemia, Dyslipidemia, Liver and Kidney Functions in Diabetic Rats

  2016cites this paper
• Receptor for Advanced Glycation End Products-Mediated Signaling Impairs the Maintenance of Bone Marrow Mesenchymal Stromal Cells in Diabetic Model Mice

  2016cites this paper
• Effect of Mesenchymal Stem Cells on Diabetic Nephropathy in Experimental Animals

  2016cites this paper
• Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy.

  2016cites this paper
• Transplantation of human amnion mesenchymal cells attenuates the disease development in rats with collagen-induced arthritis.

  2015cites this paper
• Human Amniotic Fluid-Derived and Amniotic Membrane-Derived Stem Cells

  2015cites this paper
• Recent Patents and Advances in Regenerative Medicine and Stem Cell Therapies for Diabetes, Cardiovascular and Neurodegenerative Diseases

  2015cites this paper
• Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus

  2015cites this paper
• Adipose-Derived Mesenchymal Stem Cells Transplantation Alleviates Renal Injury in Streptozotocin-Induced Diabetic Nephropathy

  2015cites this paper
• TRB3, up-regulated in kidneys of rats with type1 diabetes, mediates extracellular matrix accumulation in vivo and in vitro.

  2014cites this paper
• AMERICAN UNIVERSITY OF BEIRUT MOLECULAR MECHANISMS UNDERLYING THE ATTENUATION OF DIABETES-INDUCED RENAL INJURIES BY MESENCHYMAL STEM CELLS

  2014influential citation